Filter
5847
Filtered Results: 5847
Text search:
group
therapy
Featured
Recommendations
536
New Publications
1502
Language
Document type
No document type
3654
Studies & Reports
808
Guidelines
758
Manuals
261
Strategic & Response Plan
123
Training Material
83
Fact sheets
79
Situation Updates
40
Infographics
15
Resource Platforms
12
Brochures
10
Online Courses
3
App
1
Countries / Regions
India
326
Global
184
Kenya
172
South Africa
144
Ethiopia
115
Uganda
112
Nigeria
111
Nepal
109
Western and Central Europe
105
Malawi
96
Tanzania
95
Zambia
94
Sierra Leone
86
Africa
80
Rwanda
71
Liberia
71
Bangladesh
68
Ghana
67
Myanmar / Burma
64
Ukraine
62
Latin America and the Carribbean
59
Eastern Europe
57
Namibia
57
Zimbabwe
48
Lesotho
45
Philippines
45
Russia
45
Asia
44
Indonesia
41
Syria
35
Congo, Democratic Republic of
35
Senegal
34
Cambodia
33
South–East Asia Region
29
Germany
28
Mozambique
24
Botswana
24
Haiti
23
South Sudan
23
Eswatini/ Swaziland
22
Burkina Faso
20
Brazil
20
Cameroon
19
West and Central Africa
17
East and Southern Africa
17
Eastern Europe and Central Asia
13
Paraguay
13
Pakistan
13
Tajikistan
12
Afghanistan
12
Guinea
12
Lebanon
12
Iraq
12
Colombia
11
Benin
11
Albania
11
USA
11
Venezuela
11
Middle East and North Africa
11
Yemen
9
Thailand
8
Jordan
8
Central African Republic
8
Madagascar
8
Peru
7
Southern Africa
7
Moldova
7
Sudan
7
Georgia
7
North Macedonia
6
Chile
6
Western Pacific Region
6
Spain
6
Vietnam
6
Sri Lanka
6
Somalia
6
Iran
5
Kyrgyzstan
5
Armenia
5
United Kingdom
5
Argentina
5
Poland
5
Ecuador
5
Turkey
4
China
4
Kazakhstan
4
Canada
4
North America
4
Bolivia
4
Egypt
4
Romania
4
Mali
4
Angola
4
Timor Leste/ East Timor
3
Laos
3
Estonia
3
Burundi
3
Hungary
3
Saudi Arabia
3
Jamaica
3
Papua New Guinea
3
Palestine
3
Mexico
2
Serbia
2
Gambia
2
Singapore
2
Niger
2
Uzbekistan
2
Qatar
2
Bulgaria
2
Lithuania
2
Gabon
2
France
2
Mauritius
2
Slovakia
2
Chad
2
Libya
2
Bhutan
2
North Korea
1
Switzerland
1
El Salvador
1
Australia
1
Togo
1
Fiji
1
Malaysia
1
Morocco
1
Mongolia
1
Guinea-Bissau
1
Ireland
1
Turkmenistan
1
Denmark
1
Belgium
1
Maldives
1
Tunisia
1
Portugal
1
Belarus
1
Latvia
1
Côte d’Ivoire / Ivory Coast
1
Djibouti
1
Greece
1
Authors & Publishers
Publication Years
Category
Countries
2188
Clinical Guidelines
564
Public Health
308
Women & Child Health
274
Key Resources
123
Capacity Building
99
Pharmacy & Technologies
52
Annual Report MEDBOX
2
Toolboxes
HIV
720
Mental Health
617
TB
452
COVID-19
287
AMR
219
Disability
201
Caregiver
157
NTDs
157
NCDs
142
Pharmacy
133
Conflict
107
Rapid Response
95
Ebola
83
Refugee
78
Planetary Health
53
Global Health Education
47
Natural Hazards
35
Health Financing Toolbox
28
Cholera
27
Polio
24
Specific Hazards
18
Social Ethics
17
Zika
14
South Sudan
1
Since the notification of the first two confirmed cases of Vibrio cholerae O1 in the greater Port-au-Prince area on 2 October 2022, to 22 October 2022, the Haitian Ministry of Health (Ministère de la Santé Publique et de la Population, MSPP per its French acronym), reported a total of 2,243 suspec...
This document provides guidance to host States on the vetting and registration of volunteers and volunteer organisations. It also provides guidance to UN, NGO and other civil society actors on how they can support and complement State efforts through operational activities.
This document provides guidance to host States on the vetting and registration of volunteers and volunteer organisations.
It also provides guidance to UN, NGO and other civil society actors on how they can support and complement State ef-forts through operational activities.
The Indigenous tribe called the Wiwa lives retracted in the Sierra Nevada de Santa Marta, Colombia. Little is known about their health status and whether the health care system in place covers their needs.
Front Chem. 2021; 9: 622286.
Published online 2021 Mar 12. doi: 10.3389/fchem.2021.622286
In 2005, the World Health Organization (WHO) recognized Chagas disease (CD; Trypanosoma cruzi infection) as a neglected tropical disease (NTD) [1] and included it into the global plan to combat NTDs [2]. The Target 3.3 of the United Nations Sustainable Development Goals (UN/SDG) aims at ending the e...
To support its R&D activities on Chagas disease, DNDi launched the Chagas Clinical Research Platform (CCRP). The platform brings together partners, experts, and stakeholders to provide support for evaluation and development of new treatments for Chagas disease. The patient-centred platform aims to f...
Female Genital Schistosomiasis (FGS) is a gynaecological disease caused by Schistosoma haematobium, a parasitic worm that is acquired by skin contact with freshwater contaminated by schistosome cerceriae. Communities in which the infection is most endemic have limited access to clean water and healt...
Arsenical monotherapies were previously very successful for treating human African trypanosomiasis (HAT).
Melarsoprol resistance emerged as early as the 1970s and was widespread by the late 1990s.
Melarsoprol resistance represents the only example of widespread drug resistance in HAT patients wher...
Over the past twenty years, huge efforts made by a broad coalition of stakeholders curbed the last epidemic and brought the disease to the brink of elimination. In this paper, the latest figures on disease occurrence, geographical distribution and control activities are presented. Strong evidence in...
Chromoblastomycosis (CBM), represents one of the primary implantation mycoses caused by melanized fungi widely found in nature. It is characterized as a Neglected Tropical Disease (NTD) and mainly affects populations living in poverty with significant morbidity, including stigma and discrimination.
Snakebite envenoming constitutes a serious medical condition that primarily affects residents of rural communities in Africa, Asia, Latin America, and New Guinea. It is an occupational, environmental, and domestic health hazard that exacerbates the already impoverished state of these communities. Co...
The conditionality of this recommendation is largely driven by the current higher unit cost of pyrethroid-PBO ITNs compared
to pyrethroid-only LLINs and therefore the uncertainty of their cost-effectiveness. Furthermore, as PBO is less wash-resistant
than pyrethroids, its bioavailability declines ...
Rabies is a disease of animals but too often the outcome is gauged in terms of human suffering and
death. Despite this, in areas of the world where rabies is endemic there is often a lack of communication between veterinary and medical professionals, to the extent that the disease continues to thri...
The publication of the of the Antimicrobial Treatment Guidelines represents the
culmination of the efforts of the Antimicrobial Stewardship Program of ICMR to publish treatment guidelines for common syndromes in India. These guidelines are targeted for the health care settings. It aims to rationali...
Background: One of the objectives of the Global Action Plan by the World Health Organization (WHO) to contain antimicrobial resistance (AMR), is to improve global awareness through effective communication and education. Comprehensive information on the level of awareness of AMR among Nigerian public...
Glaucoma is a leading cause of irreversible blindness globally. In Malawi, glaucoma accounts for 15.8% of the blindness among people aged 50 years and above. Blindness from glaucoma is preventable with early detection and timely treatment. However, glaucoma management remains a challenge to eye care...
Training in monitoring and epidemiological assessment of mass drug administration for eliminating lymphatic filariasis: learners’ guide. World Health Organization.
The Strategic Plan of Action and Budget 2016-2025 for the elimination of onchocerciasisin countries was prepared based on the above dlrective for the consideration of IAF 18.The vision of the plan of action is to eliminate onchocerciasis in 80 percent of Africancountries. Implementation of the plan ...
This publication describes the first WHO public-benefit Target Product Profiles (TPPs) for snakebite antivenoms. It focuses on antivenoms for treatment of snakebite envenoming in sub-Saharan Africa. Four TPPs are described in the document:
Broad spectrum Pan-African polyvalent antivenoms: products ...
